Blend Labs price target lowered to $5 from $7 at Citizens
Citizens analyst Aaron Kimson lowered the firm’s price target on Blend Labs (BLND) to $5 from $7 and keeps an Outperform rating on the shares. The company reported “strong” Q4 results but its Q1 guidance is “disappointing,” the analyst tells investors in a research note. Citizens reduced estimates but says the financial institution customers Blend serves will want to stay in the mortgage business.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Read More on BLND:
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Rare Earths Americas doubles mineralized zone at Homer project in Brazil
Wall Street Trading Booms on Crypto Exchanges. Which Tokens Benefit?
CEREBRAS SYSTEMS INC <CBRS.O>: MIZUHO CUTS TARGET PRICE TO $240.00 FROM $300.00
Allarity Therapeutics Sees FY Loss/Shr 73c-Loss 76c >ALLR
Crypto prices
More
